Raph
Hamers
I am an internist and infectious disease physician, trained in The Netherlands, employed by Oxford University and based at the Eijkman-Oxford Clinical Research Unit (EOCRU) in Jakarta, Indonesia. I have over 10 years of experience in research projects in sub-Saharan Africa and southeast Asia. I hold a PhD (Cum Laude) from the University of Amsterdam.
EOCRU was created in 2007 by agreement between the Eijkman Institute for Molecular Biolology (EIMB, Ministry of Science & Technology) and the University of Oxford to collaborate on clinical, laboratory, and field research on infectious diseases of public health importance in Indonesia, and operates under the auspices of the Oxford University Clinical Research Unit in Vietnam (OUCRU).
EOCRU seeks to actively expand its research agenda in infectious diseases in Indonesia, with a focus on clinical trials. We currently conduct clinical trials on adjunctive dexamethasone in tuberculous meningitis in HIV-infected adults (ACT-HIV); tafenoquine for the radical cure of Plasmodium vivax malaria (INSPECTOR); and Plasmodium falciparum sporozoite vaccine (PfSPZ).
In 2017, I joined EOCRU as a clinical scientist to develop and broaden the clinical research agenda, and to lead the newly established Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL), serving as the administrative, regulatory, and technical hub for clinical trials. In this role, I am actively exploring opportunities to initiate high-impact collaborative research in infectious diseases, including in vaccines.
My major areas of interest are in HIV and opportunistic infections, tuberculosis, antimicrobial drug resistance, NTDs, and in multidisciplinary approaches to improve health outcomes in low-resource settings. EOCRU has an interest to expand the research portfolio including vaccine field trials for infectious diseases with relevance for Indonesia, for example Str. pneumoniae, Mycobacterium tuberculosis, Burkholderia pseudomallei and Mycobacterium leprae.